1
|
Toussaint M, Buggenhoudt L, Pelc K. Nocturnal Transcutaneous Blood Gas Measurements in a Pediatric Neurologic Population: A Quality Assessment. Dev Neurorehabil 2021; 24:303-310. [PMID: 33423573 DOI: 10.1080/17518423.2020.1869336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Objective: To assess the quality of SpO2 and PCO2 recordings via transcutaneous monitoring in children with neurological conditions.Methods: Overnight transcutaneous SpO2 and PCO2 were analyzed. The presence of drift and drift correction was noted, and the rate of disrupted recordings scored (0: absence, 1; presence). The quality of recordings was also scored (0, 1, 2 for poor, medium, and high).Results: A total of 228 recordings from 64 children aged 9.7 ± 6 years were analyzed of which 42 used positive pressure respiratory support. The mean quality of the recordings was scored as 1.27 (0-2). PCO2 drift, drift correction, and disrupted recordings were present in 25%, 58%, and 26% of recordings, respectively. Satisfactory clinical decisions were taken in 91% of cases.Conclusion: The quality of transcutaneous sensor recordings was acceptable and clinical findings were deemed as satisfactory in the large majority of cases. Correction of PCO2 drift was challenging.
Collapse
Affiliation(s)
| | | | - Karine Pelc
- Rehabilitation Hospital Inkendaal, Vlezenbeek, Belgium
| |
Collapse
|
2
|
Hov B, Andersen T, Toussaint M, Vollsæter M, Mikalsen IB, Indrekvam S, Hovland V. Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study. Dev Med Child Neurol 2021; 63:537-544. [PMID: 33393110 PMCID: PMC8048789 DOI: 10.1111/dmcn.14797] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/25/2020] [Indexed: 01/04/2023]
Abstract
AIM To determine the prevalence of long-term mechanical insufflation-exsufflation (MI-E) and concomitant mechanical ventilation in children with neurological conditions, with reported reasons behind the initiation of treatment. METHOD This was a population-based, cross-sectional study using Norwegian national registries and a questionnaire. RESULTS In total, 114 of 19 264 children with a neurological condition had an MI-E device. Seventy-three of 103 eligible children (31 females, 42 males), median (min-max) age of 10 years 1 month (1y 5mo-17y 10mo), reported their MI-E treatment initiation. Overall, 76% reported airway clearance as the main reason to start long-term MI-E. A prophylactic use was mainly reported by children with neuromuscular disorders (NMDs). Prevalence and age at initiation differed by diagnosis. In spinal muscular atrophy and muscular dystrophies, MI-E use was reported in 34% and 7% of children, of whom 83% and 57% respectively received ventilator support. One-third of the MI-E users were children with central nervous system (CNS) conditions, such as cerebral palsy and degenerative disorders, and ventilator support was provided in 31%. The overall use of concomitant ventilatory support among the long-term MI-E users was 56%. INTERPRETATION The prevalence of MI-E in a neuropaediatric population was 6 per 1000, with two-thirds having NMDs and one-third having conditions of the CNS. The decision to initiate MI-E in children with neurological conditions relies on clinical judgment. WHAT THIS PAPER ADDS The prevalence and age at initiation of mechanical insufflation/exsufflation (MI-E) differed between diagnoses. MI-E was most commonly used in spinal muscular atrophy, where it generally coincided with ventilatory support. One-third of MI-E devices were given to children with central nervous system conditions, and one-third also received ventilatory support.
Collapse
Affiliation(s)
- Brit Hov
- Division of Paediatric and Adolescent MedicineOslo University HospitalOsloNorway,Institute of Clinical MedicineUniversity of OsloOsloNorway
| | - Tiina Andersen
- Norwegian Advisory Unit on Long‐term Mechanical VentilationThoracic DepartmentHaukeland University HospitalBergenNorway,Physiotherapy DepartmentHaukeland University HospitalBergenNorway
| | - Michel Toussaint
- Centre for Neuromuscular Disorders and Home Mechanical VentilationUZ Brussel‐InkendaalVlezenbeekBelgium
| | - Maria Vollsæter
- Norwegian Advisory Unit on Long‐term Mechanical VentilationThoracic DepartmentHaukeland University HospitalBergenNorway,Department of PaediatricsHaukeland University HospitalsBergenNorway,Department of Clinical ScienceUniversity of BergenBergenNorway
| | - Ingvild B Mikalsen
- Department of Clinical ScienceUniversity of BergenBergenNorway,Department of Paediatric MedicineStavanger University Hospital HFStavangerNorway
| | - Solfrid Indrekvam
- Norwegian Advisory Unit on Long‐term Mechanical VentilationThoracic DepartmentHaukeland University HospitalBergenNorway
| | - Vegard Hovland
- Division of Paediatric and Adolescent MedicineOslo University HospitalOsloNorway
| |
Collapse
|
3
|
Laventhal NT, Graham RJ, Rasmussen SA, Urion DK, Kang PB. Ethical decision-making for children with neuromuscular disorders in the COVID-19 crisis. Neurology 2020; 95:260-265. [PMID: 32482844 DOI: 10.1212/wnl.0000000000009936] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Accepted: 05/22/2020] [Indexed: 11/15/2022] Open
Abstract
The sudden appearance and proliferation of coronavirus disease 2019 has forced societies and governmental authorities across the world to confront the possibility of resource constraints when critical care facilities are overwhelmed by the sheer numbers of grievously ill patients. As governments and health care systems develop and update policies and guidelines regarding the allocation of resources, patients and families affected by chronic disabilities, including many neuromuscular disorders that affect children and young adults, have become alarmed at the possibility that they may be determined to have less favorable prognoses due to their underlying diagnoses and thus be assigned to lower priority groups. It is important for health care workers, policymakers, and government officials to be aware that the long-term prognoses for children and young adults with neuromuscular disorders are often more promising than previously believed due to a better understanding of the natural history of these diseases, benefits of multidisciplinary supportive care, and novel molecular therapies that can dramatically improve the disease course. Although the realities of a global pandemic have the potential to require a shift from our usual, highly individualistic standards of care to crisis standards of care, shifting priorities should nonetheless be informed by good facts. Resource allocation guidelines with the potential to affect children and young adults with neuromuscular disorders should take into account the known trajectory of acute respiratory illness in this population and rely primarily on contemporary long-term outcome data.
Collapse
Affiliation(s)
- Naomi T Laventhal
- From the Division of Neonatal-Perinatal Medicine (N.T.L.), Department of Pediatrics, University of Michigan School of Medicine and C.S. Mott Children's Hospital; Center for Bioethics and Social Sciences in Medicine (N.T.L.), University of Michigan, Ann Arbor, MI; Department of Anesthesiology (R.J.G.), Critical Care and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia (R.J.G.), Harvard Medical School, Boston, MA; Department of Pediatrics (S.A.R.), University of Florida College of Medicine; Department of Epidemiology (S.A.R.), University of Florida College of Medicine and College of Public Health and Health Professions, Gainesville, FL; Department of Neurology (D.K.U.), Boston Children's Hospital and Harvard Medical School, Boston, MA; Division of Pediatric Neurology (P.B.K.), Department of Pediatrics, University of Florida College of Medicine; and Department of Neurology and Department of Molecular Genetics and Microbiology (P.B.K.), University of Florida College of Medicine, Gainesville, FL
| | - Robert J Graham
- From the Division of Neonatal-Perinatal Medicine (N.T.L.), Department of Pediatrics, University of Michigan School of Medicine and C.S. Mott Children's Hospital; Center for Bioethics and Social Sciences in Medicine (N.T.L.), University of Michigan, Ann Arbor, MI; Department of Anesthesiology (R.J.G.), Critical Care and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia (R.J.G.), Harvard Medical School, Boston, MA; Department of Pediatrics (S.A.R.), University of Florida College of Medicine; Department of Epidemiology (S.A.R.), University of Florida College of Medicine and College of Public Health and Health Professions, Gainesville, FL; Department of Neurology (D.K.U.), Boston Children's Hospital and Harvard Medical School, Boston, MA; Division of Pediatric Neurology (P.B.K.), Department of Pediatrics, University of Florida College of Medicine; and Department of Neurology and Department of Molecular Genetics and Microbiology (P.B.K.), University of Florida College of Medicine, Gainesville, FL
| | - Sonja A Rasmussen
- From the Division of Neonatal-Perinatal Medicine (N.T.L.), Department of Pediatrics, University of Michigan School of Medicine and C.S. Mott Children's Hospital; Center for Bioethics and Social Sciences in Medicine (N.T.L.), University of Michigan, Ann Arbor, MI; Department of Anesthesiology (R.J.G.), Critical Care and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia (R.J.G.), Harvard Medical School, Boston, MA; Department of Pediatrics (S.A.R.), University of Florida College of Medicine; Department of Epidemiology (S.A.R.), University of Florida College of Medicine and College of Public Health and Health Professions, Gainesville, FL; Department of Neurology (D.K.U.), Boston Children's Hospital and Harvard Medical School, Boston, MA; Division of Pediatric Neurology (P.B.K.), Department of Pediatrics, University of Florida College of Medicine; and Department of Neurology and Department of Molecular Genetics and Microbiology (P.B.K.), University of Florida College of Medicine, Gainesville, FL
| | - David K Urion
- From the Division of Neonatal-Perinatal Medicine (N.T.L.), Department of Pediatrics, University of Michigan School of Medicine and C.S. Mott Children's Hospital; Center for Bioethics and Social Sciences in Medicine (N.T.L.), University of Michigan, Ann Arbor, MI; Department of Anesthesiology (R.J.G.), Critical Care and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia (R.J.G.), Harvard Medical School, Boston, MA; Department of Pediatrics (S.A.R.), University of Florida College of Medicine; Department of Epidemiology (S.A.R.), University of Florida College of Medicine and College of Public Health and Health Professions, Gainesville, FL; Department of Neurology (D.K.U.), Boston Children's Hospital and Harvard Medical School, Boston, MA; Division of Pediatric Neurology (P.B.K.), Department of Pediatrics, University of Florida College of Medicine; and Department of Neurology and Department of Molecular Genetics and Microbiology (P.B.K.), University of Florida College of Medicine, Gainesville, FL
| | - Peter B Kang
- From the Division of Neonatal-Perinatal Medicine (N.T.L.), Department of Pediatrics, University of Michigan School of Medicine and C.S. Mott Children's Hospital; Center for Bioethics and Social Sciences in Medicine (N.T.L.), University of Michigan, Ann Arbor, MI; Department of Anesthesiology (R.J.G.), Critical Care and Pain Medicine, Boston Children's Hospital and Department of Anaesthesia (R.J.G.), Harvard Medical School, Boston, MA; Department of Pediatrics (S.A.R.), University of Florida College of Medicine; Department of Epidemiology (S.A.R.), University of Florida College of Medicine and College of Public Health and Health Professions, Gainesville, FL; Department of Neurology (D.K.U.), Boston Children's Hospital and Harvard Medical School, Boston, MA; Division of Pediatric Neurology (P.B.K.), Department of Pediatrics, University of Florida College of Medicine; and Department of Neurology and Department of Molecular Genetics and Microbiology (P.B.K.), University of Florida College of Medicine, Gainesville, FL.
| |
Collapse
|